When it comes to cancer, although treatment is essential, it is often exhausting, long, and strenuous on the body, but ...

New York Oncology Hematology’s multidisciplinary facility will provide a “coordination of care doesn’t really exist locally ...

In this video, Chandler S. Cortina, MD, MS, FACS, discusses a cohort study that highlights the importance of additional research on breast cancer screening and treatment among transgender, nonbinary ...

JOHNSON CITY — In an ongoing commitment to increase access to quality oncology and hematology services in the Appalachian ...

Nurse Kristen Waller has come full circle. Once a baby fighting cancer at Texas Children's Hospital, her journey inspired her ...

New York Oncology Hematology (NYOH) has officially broken ground on a new state-of-the-art regional cancer center in ...

CHICAGO — Counties in the U.S. with the highest environmental burden, such as increased pollution, had significantly higher cancer incidence among multiple malignancy types compared with areas ...

Heme Malignancies Program: TScan’s two lead TCR-T therapy candidates, TSC-100 and TSC-101, are designed to treat residual disease and prevent relapse in patients with acute myeloid leukemia (AML ...

STATEN ISLAND, N.Y. – Staten Island University Hospital (SIUH) has appointed Dr. Thomas Bradley director of hematology and oncology at the Florina Cancer Center in Ocean Breeze to spearhead the ...

The SSM Health/Saint Louis University Division of Hematology and Medical Oncology offers a three ... Our physicians' interests include breast cancer, lymphomas, leukemias, head and neck tumors, GI ...

Attivare will use MSR biomaterial scaffolds like this to first develop treatments for patients with solid tumors and heme malignancies who do not respond to immunotherapies yet. The immune ...

"This is an exciting year for TScan as we advance our mission of bringing life-changing T-cell therapies to patients with both heme and solid tumor malignancies,” said Gavin MacBeath, Ph.D ...